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Abstract
Recent interest has focused on the importance of the nucleus and associated nucleoskeleton in regulating changes in
cardiac gene expression in response to biomechanical load. Mutations in genes encoding proteins of the inner nuclear
membrane and nucleoskeleton, which cause cardiomyopathy, also disrupt expression of a biomechanically responsive gene
program. Furthermore, mutations in the outer nuclear membrane protein Nesprin 1 and 2 have been implicated in
cardiomyopathy. Here, we identify for the first time a role for the outer nuclear membrane proteins, Nesprin 1 and Nesprin
2, in regulating gene expression in response to biomechanical load. Ablation of both Nesprin 1 and 2 in cardiomyocytes, but
neither alone, resulted in early onset cardiomyopathy. Mutant cardiomyocytes exhibited altered nuclear positioning, shape,
and chromatin positioning. Loss of Nesprin 1 or 2, or both, led to impairment of gene expression changes in response to
biomechanical stimuli. These data suggest a model whereby biomechanical signals are communicated from proteins of the
outer nuclear membrane, to the inner nuclear membrane and nucleoskeleton, to result in changes in gene expression
required for adaptation of the cardiomyocyte to changes in biomechanical load, and give insights into etiologies underlying
cardiomyopathy consequent to mutations in Nesprin 1 and 2.
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Introduction
Mechanical cues from the extracellular matrix (ECM) trans-
mitted through the cytoskeleton to the nucleoskeleton are regu-
lated by a unique set of structural protein complexes [1,2]. These
mechanotransducers function as a platform to translate mechan-
ical cues into biochemical signals and effect a wide range of
biological functions (development, migration, cell specification)
[2]. Recent attention has turned to protein complexes at the
nucleus, their regulation of mechanotransduction and how these
structures affect the biomechanical properties of the cell and tissue
[1]. Indeed, a number of pathologies, including dilated cardiomy-
opathy (DCM) and Emery-Dreifuss muscular dystrophy (EDMD),
arise from mutations within cardiomyocyte structural proteins
affecting mechanical signal integration [3,4]. Given this, better
understanding of structural proteins within the nucleus involved in
sensing biomechanical load and enabling adaptive cellular respons-
es during cardiovascular development and pathology can lend
significant insight into our understanding of cardiac function [5].
The nucleus itself is separated from the cytoplasm via the
nuclear envelope (NE) which is comprised of two membranes; the
Outer Nuclear Membrane (ONM) and the Inner Nuclear
Membrane (INM) [6–8]. Both the ONM and INM contain
elements of a protein complex that mechanically link the nucleo-
skeleton to the cytoskeleton termed the LINC complex (linker of
nucleoskeleton and cytoskeleton). The LINC complex is com-
prised of a number of proteins from two families, the SUN proteins
(Sad1p/UNC-84) anchored within the INM, and the Nesprins at
the ONM [9–13].
The Nesprin family is comprised of four members (Nesprin 1–4)
that anchor nuclei to the actin cytoskeleton, intermediate filaments
and the microtubule cytoskeleton. Two members, Nesprin 1 and
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2, link the nuclear lamina to the actin cytoskeleton and share 65%
homology [9,11,13–16]. Both Nesprin 1 and Nesprin 2 use alter-
native promoters, RNA splicing and termination to give rise to
multiple isoforms, ranging from 61 kDa–1.01 MDa, with the two
largest being the giant Nesprins 1G (1.01 MDa) and Nesprin 2G
(796 KDa) [9,12,17]. Structurally, Nesprin 1G and 2G contain
two N-terminal Calponin-homology (CH) domains responsible for
linkage to the actin cytoskeleton, a number of Spectrin-repeat (SR)
rod domains and a C-terminal KASH (Klarsicht/Anc/Syne
Homology) domain [11,12,14–16,18]. The KASH domain is key
in the interaction of Nesprins with their LINC complex partners,
SUN proteins. Recent crystal structures have shown that Nesprin
1 or 2 function in the LINC complex by localizing to the ONM
and linking to a homotrimeric SUN domain containing protein
complex (either SUN1 or SUN2) via the KASH domain at the
INM [19,20].
In addition to Nesprin and SUN proteins, the INM contains a
number of LINC associated factors, including the nuclear lamina,
comprised of both A- and B- type Lamins and Emerin. The
Lamins are type V intermediate filaments that comprise the
protein meshwork that lines the INM and physically associate with
the LINC complex via direct interactions with SUN proteins. A-
type lamins (Lamin A and C) are alternatively spliced isoforms of
the LMNA gene, whereas B-type lamins (Lamin B1 and B2) are
encoded by two separate genes LMNB1 and LMNB2 [21]. Emerin,
encoded by EMD, is an integral INM protein that can interact
with both SUN and Lamin A/C and affects mechanical load
responses in cells [22]. Both of these LINC associated factors were
found at the cellular level to be critical for mechanotransduction,
cellular stiffness, nuclear positioning and nuclear envelope
integrity in a number of cell types [21–25]. These data suggest
that other factors in the nucleus could also affect mechanical
loading and nuclear structure/positioning.
Mutations in both LMNA and EMD have been observed to
cause a number of diseases including autosomal dominant EDMD
and X-linked EDMD (X-EDMD), respectively [26]. EDMD is
characterized by skeletal muscle wasting, cardiac conduction
defects and cardiomyopathy [26]. Interestingly, 60% of cases of
EDMD do not have mutations in LMNA or EMD. Recently,
mutations in both Nesprin 1 and 2 were observed to cause EDMD
phenotypes [27]. Furthermore, Nesprin 1a mutations were
observed in patients with non-ischemic dilated cardiomyopathy
(DCM) [28]. Isolated skin fibroblasts from these patients were also
observed to have altered nuclear shape [27,28]. These data
indicate that Nesprins may also play a role in cardiac pathology.
Taken together, these data lead to the intriguing possibility that
Nesprins could play a role in nuclear function, mechanotransduc-
tion, cardiac function and pathology. However, the roles of
Nesprins, in particular Nesprin 1 and 2, in cardiomyocyte
mechanotransduction and overall cardiac function are largely
unknown. Studies as to the function of Nesprin 1 and 2 in
cardiomyocytes have been limited, given that dual global ablation
of both factors results in postnatal lethality with respiratory defects
[29]. Thus, to elucidate the role of Nesprin 1 and 2 in cardio-
myocytes, we generated a number of knockout mouse lines in
which Nesprin 1 and/or Nesprin 2 are ablated in cardiomyocytes.
We demonstrate that ablation of both Nesprin 1 and 2 causes an
early onset cardiomyopathy. Moreover we show that Nesprin 1
and 2 play a key role in the integration of biomechanical loading
in cardiomyocytes. Taken together, analysis of these targeted
ablation models have revealed that Nesprin 1 and 2 play critical
roles in cardiomyocyte mechanobiology.
Results
Establishment of Nesprin 1 and 2 global null or
cardiomyocyte specific knockout mice
To examine the role(s) of Nesprin 1 and 2, we generated a
number of mouse lines in which all KASH-domain containing
isoforms were floxed. Nesprin 1 global knockout mice were
generated as previously described [13]. These mice were observed
to not have a cardiac phenotype at one year of age, but did have
severe skeletal muscle defects and some postnatal lethality [13].
Nesprin 2 global knockout mice were developed as previously
described [13]. Briefly, we floxed the 7th exon counting backwards
from the last exon of Nesprin 2 (Supplemental Figure. S1A).
Targeted ES cells were confirmed using Southern blot analyses
(Supplemental Figure. S1B). Chimeric males were bred to Black
Swiss females to generate nesprin2f/+;neo+ mice. These mice were
then crossed to Protamine-cre mice and bred to homozygosity as
previously described to generate global knockout mice (nesprin 22/2)
[30]. Deletion of Nesprin 2 was confirmed via PCR from tails,
semi-quantitative PCR from hearts and Real Time PCR from
isolated cardiomyocytes (Supplemental Figure. S1C,D,G). Dele-
tion was confirmed at the protein level via immunostaining in
both cardiac fibroblasts and myocytes (Supplemental Figure.
S1E,F). These mice were viable and did not present cardiac
defects (see below), skeletal muscle defects (data not shown) or
lethality at 1 year of age.
It has been reported the global ablation of both Nesprin 1 and
Nesprin 2 results in neonatal lethality with respiratory defects [29].
To investigate the specific role of Nesprin 1 and/or 2 in myocytes,
we established mouse lines in which one or both factors were
ablated in cardiomyocytes. To minimize incomplete Cre-mediated
excision in the presence of four floxed alleles, we generated
Nesprin 1 and 2 double knockout mice with cardiac specific
Nesprin 1 deletion, using mice which were positive for Nkx2.5Cre
[31,32], homozygous floxed for Nesprin 1, and germline
homozygous null for Nesprin 2 (nesprin 1f/f;nesprin 22/2;Nkx2.5Cre).
Excision of Nesprin 1 was observed to be ,8865% (n= 4 hearts)
using isolated adult cardiomyocytes (Supplemental Figure S2).
nesprin 1
f/f
;nesprin 22/2;Nkx2.5Cre knockout mice were observed to
Author Summary
Cardiomyopathy is one of the major causes of heart failure,
and the leading cause of mortality in the western world. A
number of cardiomyopathies are caused by genetic
mutations in structural proteins within the cardiomyocyte.
Recent interest has turned to structural proteins that link
the nucleoskeleton to the cytoskeleton (The LINC com-
plex). Disruption of these factors cause both mechanical
and gene response changes that cause varying degrees of
pathology. In particular two genes, Nesprins 1 and 2 are of
key interest as they share a high degree of homology and
both have been found in Emery-Dreifuss muscular dystro-
phy (EDMD) patients with cardiomyopathy. Studies of
these factors in the heart; however, have been limited due
to early lethality of dual ablation of both Nesprins 1 and 2
in global knockout mice. Here, we examine targeted
genetic ablation of Nesprin 1 and/or Nesprin 2 in a novel
set of mouse lines. These studies found that loss of these
factors caused early onset of cardiomyopathy, changes in
nuclear position and morphology, as well as inhibition of
the biomechanical gene response. Together, these data
demonstrate that Nesprin 1 and 2 play critical and
overlapping roles in the heart during homeostasis and
pathology.
Targeted Cardiac Ablation of Nesprin 1 and 2
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be viable and born at normal Mendelian ratios. These mice also
did not have any significant lethality at 1 year of age, compared to
Wild Type controls. nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;
nesprin 22/2mice were used to model single deletion of Nesprin 1 or
2 respectively.
Dual Ablation of Nesprin 1 and 2 in myocardium results
in early onset cardiomyopathy
As demonstrated by our previous studies, global Nesprin 1
knockout mice do not have a cardiac phenotype [13]. These data
suggest that there is a potential overlap of function of both Nesprin
1 and 2. We first examined effects of ablation of both Nesprins 1
and 2 on cardiac function, via echocardiographic analyses. Mice
from all four conditions were examined at 5, 10, 25 and 52 weeks
of age. Wild Type, nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;
nesprin 22/2 mice did not have any functional defects over the time
course examined (Figure 1). At 5 weeks of age, nesprin 1f/f;nesprin
22/2;Nkx2.5Cre were not observed to have any cardiac functional
defects or myocardial wall thinning (Figure 1). Examination at 10
weeks of age found that nesprin 1f/f;nesprin 22/2;Nkx2.5Cre mice had
decreased wall thickness; measured by left ventricular anterior wall
during diastole and systole (LVAWd and LVAWs), left ventricular
posterior wall during diastole and systole (LVPWd and LVPWs )
(Figure 1A–D) and diminished fractional shortening (Figure 1E).
Examination at 25 weeks and 52 weeks found further decrease in
fractional shortening with some decrease in wall thickness. Heart
rates were not changed in these mice over the observed time
course (Figure 1F).
Given the early onset of cardiac dysfunction in nesprin 1f/f;
nesprin22/2;Nkx2.5Cre mice at 10 weeks of age, we performed
detailed analyses of these hearts at 10 weeks. Examination of HW/
BW and HW/TL ratios at this stage revealed significant increases
in nesprin 1f/f;nesprin22/2;Nkx2.5Cre hearts compared to Wild Type,
nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2
(Figure 2A,B). Real Time PCR analyses of fetal gene expression
also found significant increases in ANP and ßMHC in nesprin 1f/f;
nesprin22/2;Nkx2.5Cre hearts (Figure 2C,D). No change in aMHC
mRNA expression was observed (Figure 2E). Moreover, exami-
nation of pro-fibrotic genes procollagen1a1 and procollagen3a1 also
observed significant increases in hearts from the latter group
(Figure 2F,G). To further characterize cardiac pathology, we next
performed Masson Trichrome and Picrosirius Red examination of
nesprin 1f/f;nesprin22/2;Nkx2.5Cre hearts. Histological analyses of
hearts at 10 weeks of age also revealed fibrosis in nesprin 1f/f;
nesprin22/2;Nkx2.5Cre hearts when compared to Wild Type, nesprin
1f/f;nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2 hearts
(Figure 3B,C). We also probed our model to examine cell death
and observed increased apoptosis as measured by TUNEL
analyses at both 5 and 10 weeks in our nesprin 1f/f;nesprin22/2;
Nkx2.5Cre hearts (Figure 3D, Supplemental Figure. S3).
Deletion of both Nesprin 1 and 2 causes altered cardiac
nuclear position and shape
Previous examination of nesprin 1 global knockout mice found
altered skeletal muscle nuclear positioning [13]. In additional
studies, mice with a 61 amino-acid substitution of the KASH
domain of Nesprin 1 were observed to have elongated nuclei as
examined by H&E sectioning [28]. Moreover, examination of
nuclei in fibroblasts from patients with mutations in Nesprin 1
and/or 2 found significant morphological defects in nuclear shape
[27–29]. Therefore, we performed detailed position and shape
analyses of cardiomyocyte nuclei following ablation of Nesprin 1
and/or 2. Nesprin 1 or 2 global knockout mice were crossed into
the Obscurin-H2B-GFP line, allowing for examination of all
cardiomyocyte nuclei [33]. Qualitative vibratome thick section
(,30 mm) analyses revealed that loss of Nesprin 1 or 2 caused an
elongation of cardiomyocyte nuclei (Supplemental Figure S4).
Examination of H&E sections from Wild Type, nesprin 1f/f;nesprin
2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2 hearts also showed
elongation and positional changes in myocyte nuclei, as indicated
by black arrows (Figure. 3A). These changes were exacerbated in
nesprin 1f/f;nesprin 22/2;Nkx2.5Cre hearts also as indicated by black
arrows (Figure 3A).
To quantitate morphological differences observed in cardiomy-
ocyte nuclei following ablation of Nesprin 1 and/or 2 we isolated
cardiomyocytes from 10-week-old hearts and examined morphol-
ogy using immunofluorescent and computational morphometric
analyses (Figure 4A,D–F). Loss of either Nesprin 1 or 2 (nesprin 1f/f;
nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2) resulted in
increased nuclear area, perimeter and length when compared to
nuclei in Wild Type controls (Figure 4D–F). This defect was
intensified in nesprin 1f/f;nesprin22/2;Nkx2.5Cre cells (Figure 4D–F).
Moreover, nesprin 1f/f;nesprin 22/2;Nkx2.5Cre nuclei also appeared
to be less circular than Wild Type controls. To quantify this we
examined circularity of nuclei as previously described [34]. Here
loss of either Nesprin 1 or 2 (nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre and
nesprin 1f/f;nesprin 22/2) was found to decrease nuclear circularity.
Loss of both Nesprin 1 and 2 (nesprin 1f/f;nesprin22/2;Nkx2.5Cre)
also intensified loss of circularity in these nuclei (Figure 4C). No
change in myocyte area was observed (Figure 4B).
Studies of the murine heart have shown that ,95 to 98% of
cardiomyocytes are binucleated [35,36]. Loss of Nesprin 1 and/or
2 appeared to decrease the distance between the two nuclei
(Figure 3A, Supplemental Figure S3). To quantify this, centroid
position was determined for each nuclei and distance from the
center of one nucleus to the center of the other was determined.
Distance between nuclei was significantly decreased with loss of
either Nesprin 1 or 2 (nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;
nesprin 22/2). Inter-nuclear distance decreased from 41 mm67.1 in
Wild Type cells to 25 mm62.8 or 30 mm61.0 in nesprin 1f/f;nesprin
2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2 cells respectively
(Figure 4A,G). Again, loss of both Nesprin alleles (nesprin 1f/f;nesprin
22/2;Nkx2.5Cre) resulted in a more significant decrease in inter-
nuclear distance, to 12 mm64.0 (Figure 4G).
Ultrastructural nuclear abnormalities in Nesprin 1 and 2
dual ablation hearts
Given observed defects in nuclear position and circularity,
we further investigated the morphology of nesprin 1f/f;nesprin22/2;
Nkx2.5Cre nuclei. We first examined nuclei at postnatal day 1,
prior to binucleation of cardiomyocytes [35]. Postnatal day 1 (P1)
cardiomyocyte nuclei did not appear to be altered in nesprin 1f/f;
nesprin 2+/+;Nkx2.5Cre and nesprin 1f/f;nesprin 22/2 groups compared
to Wild Type (Figure 5A–C). Nuclei appeared to be oval shaped
with electron dense regions of similar size at the periphery. This
suggests that chromatin localization was not altered at P1 in
response to loss of Nesprin 1 or 2. Examination of P1 nesprin 1f/f;
nesprin 22/2;Nkx2.5Cre nuclei found these nuclei did appear to
have altered morphology with a more irregular shape compared to
Wild Type controls (Figure 5D). Interestingly, nesprin 1f/f;nesprin
22/2;Nkx2.5Cre cardiomyocyte nuclei did not appear to have an
increased number of electron dense regions, suggesting that
chromatin localization was not altered at P1 in dual Nesprin 1 and
2 knockout hearts.
We then examined cardiomyocyte nuclei by electron microsco-
py at 10 weeks, after the onset of cardiac dysfunction and
binucleation [35]. At 10 weeks of age, Wild Type cardiomyocyte
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nuclei appeared to be oval in shape with a thin peripheral electron
dense heterochromatin proximal to the INM (Figure 5E). Nesprin
1 ablated (nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre) nuclei had an increased
number of invaginations and increased perimeter, in agreement
with immunofluorescent analyses. Again, these nuclei did not have
altered electron dense heterochromatin at the INM (Figure 5F).
Nesprin 2 knockout (nesprin 1f/f;nesprin 22/2) nuclei also appeared
elongated with increased perimeter, but not an increase number of
invaginations (Figure 5G). These nuclei also did not have any
alterations in electron dense heterochromatin at the INM
(Figure 5G). Interestingly, ablation of both Nesprin 1 or 2 (nesprin
1f/f;nesprin 22/2;Nkx2.5Cre) resulted in significantly altered nuclear
appearance. These nuclei were elongated compared to Wild Type
controls, with regions of electron dense chromatin distal to the
INM (red arrows, Figure 5H).
Dual ablation of Nesprin 1 and 2 did not alter expression,
but did alter localization, of LINC complex or LINC
complex associated factors
KASH domain containing isoforms of both Nesprin 1 and 2
have been shown to coimmunoprecipitate and colocalize with
Lamin A/C and Emerin in fibroblasts and skeletal muscle
[9,15,37,38]. Conversely, loss of Lamin A/C in deletion and
mutant fibroblasts and COS7 cells have been shown to disrupt
localization of both Nesprin 1 and 2 from the nuclear envelope
[15,39,40]. Moreover, EDMD fibroblasts with mutations in
Nesprin 1a1, Nesprin 1 or Nesprin 2 were also observed to have
disrupted Lamin A/C and Emerin localization [17,41]. Given
these data, we examined the LINC complex associated factors
(Lamin A/C, B1,B2, Emerin) as well as the LINC complex factors
(SUN 1 and 2) to look for changes in expression levels. Both
Western blot and Real Time PCR analyses revealed that
expression levels of LINC Complex and LINC complex associated
factors were not changed at the protein (Supplemental Figure S5)
or mRNA levels (Figure 6A–F). Analyses of localization of SUN 2
did not reveal any changes in localization (Supplemental Figure
S6). However, loss of both Nesprin 1 and 2 had a significant
impact on localization patterns of both Lamin A/C and Emerin
(Supplemental Figures S7 and S8).
Deletion of Nesprin 1 and 2 abrogated the nuclear
biomechanical gene response
The nucleus has been observed to be a critical integration point
of mechanotransduction, regulating gene expression and cellular
function [42]. Previous studies have indicated that the mechan-
otransduction response is abrogated following mutation or deletion
of LINC complex associated factors, Lamin A/C and Emerin
[21,22,43]. However, the role(s) of Nesprin 1 and/or 2 in the
integration of mechanotransduction within the cardiomyocyte is
unknown. To examine this, we isolated day 1 to 2 neonatal
cardiomyocytes from Wild Type, nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre,
nesprin 1f/f;nesprin 22/2 and nesprin 1f/f;nesprin22/2;Nkx2.5Cre
Figure 1. Deletion of both Nesprin 1 and 2 causes decreased cardiac wall thickness and impaired cardiac function. (A–D) Left
ventricular anterior wall during diastole and systole (LVAWd and LVAWs), Left ventricular posterior wall during diastole and systole (LVPWd and
LVPWs) at 5, 10, 25 and 52 weeks. (E) % Fractional Shortening (%FS) at 5, 10, 25, 52 weeks. (F) Heart Rate (HR) at 5, 10, 25, 52 weeks. N= 6–10 mice per
condition/timepoint. ANOVA with a post hoc Bonferroni test *p,0.05, N/C=No significant change vs. Wild Type.
doi:10.1371/journal.pgen.1004114.g001
Figure 2. Ablation both Nesprin 1 and 2 alters cardiac morphology, reactivates fetal gene program and activates profibrotic genes.
(A) and (B), 10 week old mice hearts: Morphological analyses of heart weight (HW)/body weight (BW) or HW/tibia length(TL). N = 10–11samples per
condition (C–F), Real Time PCR analyses of mRNA expression levels for (C) ANP (D) ßMHC (E) aMHC (F) Procol1a1 (G) Procol3a1 N=3–4 per condition.
N/C =No significant change, ANOVA with a post hoc Bonferroni test #p,0.01.
doi:10.1371/journal.pgen.1004114.g002
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hearts. These cells were plated onto micropatterned membranes
to ensure in vivo-like cell morphology and rod-like orientation
(Supplemental Figure S9). We then interrogated neonatal cardio-
myocytes with a strain regime that recapitulated in vivo loading
conditions, as per the literature [44,45]. Indeed, previous research
from our group has shown that anisotropic loading of neonatal rat
cardiomyocytes induces increases in expression of the known
hypertrophic markers [46]. Therefore, anisotropic biaxial loading
was applied to 14% Lagrangian strain along the culture transverse
axis, and 3.6% along the culture longitudinal axis using custom
stretchers as previously described [47,48].
Examination of known biomechanical response genes (egr-1, iex-
1, c-jun, c-fos and c-myc) [21,22,49] via Real Time PCR found
increased levels of these factors after 30 min of load in Wild Type
cardiomyocytes (Figure 7A–E). Nesprin 1 loss (nesprin 1f/f;nesprin
2+/+;Nkx2.5Cre) resulted in a blunted response in levels of egr-1, iex-
1, c-jun and c-fos mRNAs, with no alterations in response of c-myc
mRNA. Nesprin 2 loss (nesprin 1f/f;nesprin 22/2) resulted in blunted
response of egr-1, iex-1 and c-fos mRNAs with no alterations in
response of c-myc or c-jun mRNAs. Interestingly, increased
expression of all factors (egr-1, iex-1, c-jun, c-fos and c-myc) were
significantly abrogated in nesprin 1f/f;nesprin 22/2;Nkx2.5Cre
cardiomyocytes (Figure 7A–E). These data suggested that while
the biomechanical response is impaired with the loss of Nesprin 1
or 2, it is strongly abrogated in the absence of both Nesprins. This
indicates that either Nesprin 1 or 2 partially compensates for the
loss of each factor in single knockouts. Furthermore, these data
suggest that Nesprins 1 and/or 2 play a significant role in the
biomechanical function of the cardiomyocyte nucleus.
Discussion
A network of molecular factors act to transmit mechanical cues
from the ECM to the cytoskeleton [2]. These mechanical forces
are transduced throughout the cell by various structural proteins
and affect the physiological functions of the organ, as well as
organelle function and positioning; including the nucleus. Indeed,
recent studies of the nucleus have suggested that it functions as a
primary integration point for response and regulation of mechan-
ical forces from the cell, and that alterations in nuclear shape or
position could alter the global functions of the cell and organ
[21,22,49,50]. Thus structural factors that mediate the integration
of biomechanical signals into the nucleus could lend significant
insight into both the physiology and pathophysiology of the
cardiomyocyte. Recent studies have highlighted the LINC
complex, and in particular the Nesprins, as being important for
nuclear mechanical function in isolated fibroblasts, clinical cardiac
pathology and skeletal muscle function [13,26–28]. Nesprins have
Figure 3. Histological and TUNEL analyses of Nesprin 1 and/or 2 ablation. (A) Representative 1006H&E images of indicated hearts. Black
arrows =Myocyte nuclei. Black bar = 80 mm. (B) and (C), Representative 406 images of (B), Picrosirius Red (Brown=nuclei, red= collagen) or (C)
Masson Trichrome (Red=Myocardium, Blue = Collagen, Black =Nuclei). Black bar = 200 mm. (D) TUNEL analyses of Nesprin 1 and/or 2 knockout hearts
at 5 Weeks or 10 Weeks. N = 3 per condition. N/C =No significant change, ANOVA with a post hoc Bonferroni test #p,0.01.
doi:10.1371/journal.pgen.1004114.g003
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Figure 4. Cardiomyocyte nuclear morphology is altered in response to loss of Nesprin 1 and/or 2. (A) Representative 406 images of
isolated cardiomyocytes (Blue =DAPI, Green=Phalloidin). White bar = 15 mm. (B–G) Morphological analyses of cardiomyocytes examining (B) Myocyte
area (C) Nuclear circularity (D) Nuclear area (E) Nuclear perimeter (F) Nuclear length or (G) Nuclear distance. N= 200–300 cells per condition, from 3–4
mice. ANOVA with a post hoc Bonferroni test *p,0.05, #p,0.01.
doi:10.1371/journal.pgen.1004114.g004
Figure 5. Examination of cardiomyocyte nuclear ultrastructure in response to loss of Nesprin 1 and/or 2. (A–D) Representative images
of postnatal day 1 myocyte nuclei from (A) Wild Type (B) nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre (C),nesprin 1f/f;nesprin 22/2 or (D), nesprin 1f/f;nesprin 22/2;
Nkx2.5Cre hearts. (E–H) Representative images of 10 week old myocyte nuclei from (E) Wild Type (F) nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre (G) nesprin 1f/f;
nesprin 22/2 or (H) nesprin 1f/f;nesprin 22/2;Nkx2.5Cre hearts. Black Bars = 1 mm. Red Arrows highlight electron dense heterochromatin defects in 10
week old nesprin 1f/f;nesprin 22/2;Nkx2.5Cre hearts.
doi:10.1371/journal.pgen.1004114.g005
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also been implicated in mechanosensing in endothelial cells under
shear stress [51]. Clinical studies have demonstrated that muta-
tions in either Nesprins 1 or 2 can result in a number of cardiac
pathologies and EDMD-like phenotypes [27,28,41]. Moreover,
studies of isolated fibroblasts from Nesprins 1 or 2 mutations
observed altered nuclear morphology and localization of the LINC
complex associated factors [27,28,41]. Taken together, these studies
have raised the intriguing possibility that Nesprins 1 and/or 2 could
play critical role(s) in cardiac function, nuclear positioning and
mechanotransduction. These types of studies in the heart have,
however, been limited in ablation models due to early neonatal
lethality in dual global Nesprin 1 and 2 double knockout mice [29].
In this study we examine the role of Nesprin 1 and/or 2 ablation(s)
in a cardiac-targeted ablation model at the tissue and cellular level.
Moreover, we sought to dissect the precise roles of these factors
within the cardiomyocyte under in vitro biomechanical load.
Studies of Nesprin loss or mutation with regards to cardiac
function have been focused on examination of Nesprin 1 KASH
domain mutants and our global knockout mice. Mice where the
KASH domain of Nesprin 1 was replaced by 61 alternate amino
acids exhibited late onset (52 weeks) cardiomyopathy and
conduction defects [27,28]. Interestingly, we did not observe
cardiac abnormalities in Nesprin 1 global knockouts at 52 weeks of
age [13]. Despite the contradictory nature of these findings, both
studies suggest that loss of Nesprin 1 alone is insufficient to cause
early onset cardiomyopathy. These data also raise the possibility
that another factor could compensate for the loss of Nesprin 1.
Given the overlap in function as well as structure of both small and
giant isoforms of Nesprins 1 and 2 [9,15,37,38], we hypothesized
that Nesprin 2 may act in a compensatory role in cardiac tissue
function. Indeed, our data found that targeted cardiomyocyte
ablation of Nesprin 1 and 2 caused an early onset of cardiac
dysfunction with increased fibrosis and fetal gene re-expression
(Figure 1–3). These data suggest that correct anchoring of the
nucleus to the cytoskeleton is a key aspect of normal physiology
and homeostasis.
Postnatal cardiomyocyte growth is characterized by unique
growth patterns in response to increased hemodynamic load
during postnatal life [52,53]. During this process, cardiomyocytes
transition from mononucleated to binucleated cells, primarily
through karyokinesis without cytokinesis [35]. Given the dynamic
nature of this process and the early onset of cardiomyopathy in
nesprin 1f/f;nesprin 22/2;Nkx2.5Cre hearts, we hypothesized that loss
of Nesprin 1 and/or 2 would cause morphological and positional
defects in cardiomyocyte nuclei. Our study clearly showed that
ablation of these factors alters nuclear positioning. Quantification
of nuclear morphology showed that at 10 weeks of age (Figure 4A–
G) cardiomyocyte nuclei were elongated, less circular and closer
together with single ablation of Nesprin 1 or 2. This phenotype
was exacerbated in dual ablation of Nesprin 1 and 2, wherein
nuclear shape and position were significantly altered upon
comparison to Wild Type controls. Moreover, TEM analyses
Figure 6. Real Time PCR analyses of LINC complex and LINC complex associated factors. (A–E) Real Time PCR analyses of (A) Lamin A/C (B)
Lamin B1 (C)Lamin B2 (D)Emerin (E)SUN1 (F)SUN2. Real Time PCR analyses are representative of N= 4–5 cardiomyocyte isolations. ANOVA with a post
hoc Bonferroni test. N/C=No significant change.
doi:10.1371/journal.pgen.1004114.g006
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indicated that loss of both Nesprin 1 and 2 resulted in an
elongated, morphologically altered nucleus (Figure 5). The ob-
served changes suggested that while loss of either Nesprin 1 or 2
causes some nuclear positioning and morphological defects, loss of
both Nesprin 1 and 2 results in more severe aberrations in normal
positioning and morphological features of cardiomyocyte nuclei.
In addition, these data also show that loss of Nesprin 1 and/or 2
also alters localization of heterochromatin and thus may have an
effect on the epigenetic status of myocyte nuclei. This in turn could
alter the transcriptome of the cell in response to normal contractile
activity or in response to stress. Further examination of this
phenomenon is needed in future studies.
Observed changes in nuclear morphology suggested that these
cells may have deficiencies in nuclear function. The ‘‘structural
hypothesis’’ of disease suggests that mutations in genes involved
in the position and tension of the nucleus can alter biomechan-
ical properties of the cell [1]. Force transmission, via the
cytoskeleton to the nucleus is mediated by the elements of the
LINC complex. Components of the LINC complex associated
factors (Lamin A/C, Emerin) have been shown to mediate
cellular response to mechanotransduction, as measured by
expression of candidate genes (egr-1, iex-1, c-fos, c-jun and c-myc)
[21,22,49]. Given that dual ablation of Nesprin 1 and 2 resulted
in cardiac defects, and severe abnormalities in nuclear position-
ing, we hypothesized that ablation of Nesprin 1 and 2 would
cause abrogation of the mechanotransduction response in
cardiomyocytes.
Biomechanical stimulation of cardiomyocytes results in upre-
gulation of biomechanically responsive genes, including egr-1, iex-1,
c-fos, c-jun and c-myc. In contrast to Wild Type controls, Nesprin 1
and 2 knockout cardiomyocytes did not exhibit upregulation of
this biomechanically responsive gene program in response to
stretch. Interestingly, single ablation of Nesprin 1 or 2 caused
selective decreases in responsiveness of some of these factors to
biomechanical load. Our data also suggested that while there are
some defects in Nesprin 1 or 2 single ablation cardiomyocytes in
both nuclei and gene responses to load, these defects may not be
enough to cause significant alterations in cardiac function.
Together, these data clearly demonstrated that Nesprins 1 and
2 play overlapping and essential roles in cardiac physiology,
maintenance and responsiveness to biomechanical load. These
data also suggested a model (Figure 8) where the presence of both
Nesprin 1 and 2 is required for cardiomyocyte nuclear positioning
and linkage to the cytoskeleton/sarcomere via the LINC complex
and LINC complex associated factors. Failing to correctly establish
these structures affects normal cardiomyocyte development and
the capacity to respond to mechanical stress, leading to impaired
cardiac function. Ablation of Nesprin 1 and 2 results in abnormal
localization of other members of the LINC complex, Emerin and
Lamin A/C. It is possible that localization or functions of other
cytoskeletal proteins, which connect to the LINC complex, are
also perturbed, which will be the subject of future studies. It should
also be pointed out that Nesprin 1 and 2 are ubiquitously
expressed and therefore it is likely that the role we have uncovered
Figure 7. Examination of biomechanical gene response in isolated neonatal cardiomyocytes fromWild Type, nesprin 1f/f;nesprin 2+/+;
Nkx2.5Cre, nesprin 1f/f;nesprin 22/2 or nesprin 1f/f;nesprin 22/2;Nkx2.5Cre hearts. (A–E)Real Time PCR analyses of mRNA expression levels for (A)
egr-1 (B) c-jun (C) iex-1 (D) c-fos and (E) c-myc. N = 3–5 stretchers/isolations per condition. ANOVA with a post hoc Bonferroni test N/C =No significant
change, *p,0.05, #p,0.01.
doi:10.1371/journal.pgen.1004114.g007
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for Nesprin in transducing biomechanical signals into gene ex-
pression in the context of cardiomyocytes is likely to be more
generally applicable to the role of Nesprin in multiple cell types.
Materials and Methods
Animal care
The UCSD Animal Care Personnel maintained all animals and
the UCSD Institutional Animal Care and Use Committee
approved all experimental procedures.
Gene targeting and generation of Nesprin 2 knockout mice
Genomic DNA fragments of Nesprin 2 were amplified from R1
ES cells using polymerase chain reaction (PCR) and used to
construct the Nesprin 2-targeting construct as previously described
(Supplemental Figure. S1A) [31]. One LoxP site was inserted into
intron 7, as counted backward from the last exon, and a second
LoxP site, together with a neomycin cassette flanked by FRT sites,
was inserted into intron 6, again as counted backward from the last
exon. The targeting construct was verified by sequencing and
linearized with the restriction enzyme NotI and electroporated
into R1 ES cells derived from 129/SvJ mice (UCSD Transgenic
and Gene Targeting Core, La Jolla, CA, USA). Targeted ES cells
were identified by Sothern blotting analysis as previously described
[54,55]. Genomic DNA from G418-resistant ES cell clones was
digested with the restriction enzyme EcoR V and hybridized with
the radiolabeled 564 bp probe generated by PCR using mouse
genomic DNAs and nesprin 2 specific primers (forward, 59-
TCCAGACAACAGGCTACACTTTACC-39 and reverse, 59-
CCAATTAAAGAATTGTAAATTTGACC-39). The WT allele
is represented as a 12.1 kb band, whereas a 10.5 kb band
represents the targeted allele. ES cells from a homologous
recombinant clone were then microinjected into C57BL/6
blastocysts. Male chimeras were bred with female Black Swiss
mice (Taconic Inc., Hudson, NY, USA) to generate germline-
transmitted heterozygous mice with a neo cassette, which were
further confirmed by PCR and Southern blot analysis of mouse-
tail DNA. The global heterozygous Nesprin 2 knockout mice were
generated by crossing floxed heterozygous mice with the
protamine-Cre transgenic mouse line as previously described [30].
Semi-quantitative RT-PCR
Total RNA of various muscle tissues was isolated using Trizol
(Invitrogen) according to the instructions of the manufacturer.
RNA amounts were measured with a photospectrometer (Biorad)
and equalized. Reverse transcriptase reaction was performed using
oligo dT17 primer and the superscript II first-strand synthesis
system (Invitrogen). Amplification of GAPDH for standardization
was done using KOD DNA polymerase (EMD-Millipore). Bands
were analyzed by agarose gel electrophoresis.
Transmission electron microscopy
For TEM, mice were anaesthetized with Ketamine with Xylene,
and subsequently perfused through the left ventricle with Tryode
buffer including 50 mM KCl, followed by fixative (2% parafor-
maldehyde, 2% glutaraldehyde in PBS, pH 7.4). The heart were
removed, diced, and kept in fixative overnight. The tissues were
washed 3 times by 0.15 M sodium cacodylate buffer and then post-
fixed with 2% OsO4 in 0.15 M sodium cacodylate buffer for one
hour. The following day, tissue was stained overnight in 2% uranyl
acetate, dehydrated, and embedded into Durcupan resin (EMD,
Gibbstown, NJ) using a standard method. Ultra-thin sections (60–
70 nm) were stained with 2% uranyl acetate and statured lead
citrate solution, and observed with a JEOL-1200EX transmission
electron microscope at an accelerating voltage of 80 kV.
Nesprin 2 antibody
Rabbit antibody of Nesprin-2 was generated against the synthetic
polypeptides: PREIQADSWRKRRES (6357–6371aa) (accession
number NP_001005510) (Abgent, Ins., US). It is modified from
human Nesprin 2 antibody [15]. Each polypeptide was conjugated
to keyhole limpet haemocyanin and the conjugates injected into
rabbits to produce polyclonal antibodies that were subsequently
affinity purified and ELISA tested to confirm specificity.
Figure 8. Model of Nesprin 1 and/or 2 loss in cardiomyocytes. (A and B) Diagrammatic representation of (A) Wild Type and (B) Nesprin 1 and
2 double knockout cardiomyocyte nuclei. (A) Wild Type nuclei are anchored to the sarcomeric structure via Nesprin 1 and 2. Application of 14%
anisotropic loading results in normal cellular biomechanical gene response (egr-1, c-jun, iex-1, c-fos and c-myc.). Cardiac development and nuclear
positioning/morphology are also normal in these cells. (B) Loss of both Nesprin 1 and 2 causes ablation of biomechanical gene response upon
application of strain. Hearts from these mice develop cardiomyopathy with fibrosis, and have altered nuclear positioning and morphology.
doi:10.1371/journal.pgen.1004114.g008
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Micropatterning of substrate, in vitro analyses of
biomechanical loading
Cardiomyocytes were cultured on a flexible, microgrooved
substrate and subjected to sustained mechanical loading according
to methods derived from previous studies [46–48]. Micropatterned
topography was created using soft photolithography and poly-
dimethylsiloxane (PDMS) molding to provide mechanical and
extracellular matrix cues to cells on three sides and permit cell
coupling across groove walls. Silicon wafer master molds were
micropatterned with SU-8 2005 negative photoresist (MicroChem
Corp., Newton, MA) using a custom photomask (Advance
Reproductions Corp., North Andover, MA). Sylgard 186 PDMS,
prepared at 10 parts base to 1 part curing agent, was spin-coated
on the molds, degassed, and thermoset at 70 degrees for 30 minutes
and at room temperature overnight. The microgrooved PDMS
was mounted in custom cell stretchers and murine laminin
(Sigma-Aldrich, St. Louis, MO) was adsorbed under 350 nm
wavelength radiation at 10 mg/ml in phosphate buffered saline
(PBS) (MediaTech, Manassas, VA). Excess protein was removed
by rinsing twice in PBS prior to plating cells. The resulting 10 mm
wide microgrooves were defined by walls 5 mm high and 10 mm
wide. Anisotropic biaxial loading was applied to 14% Lagrangian
strain along the culture transverse axis, and 3.6% along the culture
longitudinal axis. The micropatterned cultures were incubated at
37uC and 10% CO2 during the 30 minute mechanical loading.
Controls were subjected to placebo manipulations.
Isolation of neonatal cardiomyocytes
Cardiomyocytes were isolated from 1–2 day old neonatal mouse
hearts as previously described [56]. Cells were plated onto the micr-
ogrooved PDMS of the stretchers at a density of 1.5 million cardio-
myocytes in an area of 1 square inch per stretcher. Myocytes were
plated in a medium containing Dulbecco’s modified Eagle medium
and Medium 199 supplemented with 10% horse serum, 5% fetal
bovine serum, 100 units/mL penicillin, and 100 mg/mL streptomy-
cin, and incubated at 37uC and 10% CO2. At 72 hours after plating,
media changed to a low-serum media containing 5% horse serum
and 1% fetal bovine serum for another 24 hours prior to stretch.
Real Time-PCR (RT-PCR) analysis
Samples from Wild Type, nesprin 1f/f;nesprin 2+/+;Nkx2.5Cre,
nesprin 1f/f;nesprin 22/2 and nesprin 1f/f;nesprin 22/2;Nkx2.5Cre
hearts, isolated cardiomyocytes or stretch samples were homog-
enized in Trizol reagent (Invitrogen) or RNeasy Mini Kit
(QIAGEN)to isolate total RNA. First strand cDNA was generated
utilizing random hexamers and the Invitrogen Superscript II kit
(Invitrogen). Primers for RT-PCR were used as previously
described [31] or as listed in Supplementary Table 1. These
primers were optimized using control murine cDNA (data not
shown). RT-PCR reactions were performed using Sso-Fast
EvaGreen Real Time PCR (BioRad) master mix in 96 well low
profile PCR plates in the CFX96 BioRad thermocycler (BioRad).
Paraffin processing, Histology analyses
Hearts were isolated from aged-matched Wild Type, nesprin 1f/
f;nesprin 2+/+;Nkx2.5Cre, nesprin 1f/f;nesprin 22/2 and I hearts (10 week
old mice). Adult hearts were perfused with phosphate buffered saline
(PBS) supplemented with 50 mM potassium chloride and subse-
quently perfused and fixed in fresh 4% paraformaldehyde supple-
mented with 50 mM potassium chloride. Hearts were removed and
placed overnight in 4% paraformaldehyde supplemented with
50 mM potassium chloride. Hearts were then processed using
standard procedures and embedded into paraffin blocks for sectioning
(10 mm). Paraffin sections were cut and stained according to Masson
Trichrome, Picrosirius Red, or hematoxylin and eosin standard
protocols as previously described [31]. Sections on the Hamamatsu
NanoZoomer 2.0HT Slide Scanning System (Hamamatsu).
Frozen processing, TUNEL staining and analyses
For frozen sections, hearts were fresh frozen using isopentane
into frozen blocks (1:1,OCT:20%sucrose) and sections cut (7–
10 mm). Frozen sections were then post fixed and samples stained
first for a-Actinin (Abcam) and then for apoptosis using the In Situ
Cell Death Detection kit (Roche) as per manufactures instructions.
Images were taken using confocal microscopy (Olympus FV1000
Confocal) and images analyzed using ImagePro3D software
analyses (MediaCybernetics).
Langendorff perfusion of adult hearts
Dissociation of heart by Langendorff perfusion was performed
as in prior studies [57]. Briefly, hearts we perfused with collagenase
type II (Worthington) to dissociate the individual cardiomyocytes.
Isolated cells were then filtered through a 100 mm mesh nylon filter
before performing sequential sedimentation to enrich for myocytes.
Isolated myocytes were then plated onto glass-covered dishes coated
with Laminin (Sigma) for 1–2 hours.
Echocardiographic analysis
Transthoracic echocardiography was performed on mice 5 to
52 weeks (adult) as previously described [31,58]. Briefly, mice were
anesthetized using 1% isoflurane. Mice were then moved to a
biofeedback warming station. This was to maintained core body
temperature. Mice were then placed under anesthesia (1 to .5%
isoflurane). Ultrasound gel was applied to the chest of the animal.
Echocardiography measurements then were obtained using the
VEVO 2100 software package and ultrasound system with a linear
transducer 45 MHz. (Visual Sonics, SonoSite). Images were pro-
cessed and M-mode tracings were taken and measured for wall
thicknesses and interdimensional space. This was done for both
systole and diastole. Fractional shortening was calculated as previously
described [58]. An average of six cardiac cycles per animal were
analyzed. Six to ten animals were used per condition/per time point.
Western blot analysis
Isolated cardiomyocytes from Wild Type, nesprin 1f/f;nesprin 2+/+;
Nkx2.5Cre, nesprin 1f/f;nesprin 22/2 and nesprin 1f/f;nesprin 22/2;
Nkx2.5Cre hearts were lysed into buffer, run up and down into a
syringe, quantified and placed directly into SDS-sample buffer.
Samples were run on Bis-Tris gels (Invitrogen) and transferred to
membranes. Membrane was stained using Ponceau, destained and
then UV cross-linked for 10 min. Membranes were then blocked
for 1 hour with 5% milk in TBST. Membranes were then probed
with rabbit anti-Lamin A/C (a gift from Larry Gerace), anti-
Lamin B1 (a gift from Larry Gerace), anti-Lamin B2 (a gift from
Larry Gerace), anti-SUN 1 (Epitomics), anti-SUN2 (Sigma), anti-
Emerin (Santa Cruz) or mouse anti-GAPDH (Santa Cruz) for
1 hour at room temperature. Blots were then washed three times
in TBST and probed for 1 hour with secondary anti-rabbit or anti-
mouse antibody. After washing of membranes three times in TBST
for 10 minutes, membranes were developed for expression analyses.
Immunofluorescent staining
For immunofluorescent staining, isolated adult cardiomyocytes
were fixed for 30 min, room temperature with 2%PFA/PBS/
0.1%Triton x-100. Samples were then stained with antibodies for
Lamin A/C (A gift from Larry Gerace), Emerin (Santa Cruz),
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Sun2 (Sigma), a-actinin (Sigma) or Nesprin 2(Abgent). Samples
were then stained with secondary antibodies conjugated to CY3
(Jackson ImmunoResearch Inc.). Samples were then incubated
with DAPI (Invitrogen) and Phalloidin Alexa-488 (Invitrogen).
Samples then imaged using standard confocal microscopy
(Olympus FV1000 Confocal). Image analyses were then per-
formed and samples quantified using either Velocity high
performance 3D imaging software (PerkinElmer) or ImagePro3D
software analyses (MediaCybernetics).
Statistics
The data obtained from all analyses were measured for
significance via Graphpad Prism by either student-t test or
ANOVA with a post hoc Bonferroni test, P,0.05 was considered
significant. All data are 6 SEM.
Supporting Information
Figure S1 Generation of Nesprin 2 all isoforms containing C-
terminal domain knockout mice. (A) Targeting strategy. A
restriction map of the relevant genomic region of Nesprin 2 is
shown at the top, the targeting construct is shown in the middle,
and the mutated locus after recombination is shown at the bottom.
The grey box indicates an exon which is the 16th exon, as counted
backward from the last exon, triangular black boxes indicate LoxP
sites and rectangular grey boxes indicate frt sites. DTA, Diphtheria
Toxin A chain gene, Neo, Neomycin resistance gene. (B)
Detection of wildtype (WT) and knockout (KO) alleles by
Southern blot analysis. DNA from electroporated ES cells was
digested with EcoR V and analyzed by Southern Blot analysis with
a probe as shown in A. The 12.1 kb and 10.5 kb bands represent
WT and KO alleles, respectively. (C) PCR analysis of DNA
isolated from tails of Nesprin 2 WT, heterozygous and
homozygous KO mice. KO and WT mice show only one band
using specific primers for the KO or WT allele, heterozygous mice
show two bands. (D) RT-PCR analysis with RNA from muscle. No
coding sequence of the deleted exon could be amplified from the
KO sample. (E and F) Immunostaining from (E) Cardiac
Fibroblasts and (F) Cardiomyocytes (Blue =DAPI, Red=Nesprin
2) Green bar = 10 mm, White Bar = 5 mm. Green arrows indicate
nuclear membranes (G) Real Time PCR analyses of Nesprin 2
knockout from isolated cardiomyocytes. student-t test #P,0.01.
(TIF)
Figure S2 Validation of knockout of Nesprin 1 in cardiac specific
deficient mice. Nesprin 1 Real Time PCR analyses of isolated
cardiomyocytes from Wild Type, nesprin1f/f;Nkx2.5Cre and global
nesprin12/2 mice. We observed an ,88% decrease observed
nesprin1f/f;Nkx2.5Cre isolated cardiomyocytes. student-t test#P,0.01.
(TIF)
Figure S3 Representative TUNEL stain in Nesprin 1 and/or 2
knockout hearts. Blue =DAPI, Green=TUNEL, Red=a-actinin
White arrows indicate apoptotic nuclei.
(TIF)
Figure S4 Analyses of Nesprin 1 and Nesprin 2 knockout hearts.
Representative 3D reconstruction, 30 mm thick images from (A)
Wild Type;Obs-H2bGFP (B) nesprin12/2;Obs-h2b-GFP and (C)
nesprin22/2;Obs-h2b-GFP Hearts. White arrows indicate cardio-
myocyte nuclei. #p,0.01.
(TIF)
Figure S5 Western LINC complex and LINC complex
associated factors. (A) Representative western blots for Lamin
A/C, Lamin B1, Lamin B2, Emerin, SUN1, SUN2 and GAPDH.
Western samples are representative of N=3 cardiomyocyte
isolations, (B–G) Quantification of Western analyses for LINC
Complex and LINC Complex associated factors. ANOVA with a
post hoc Bonferroni test N/C=No Change.
(TIF)
Figure S6 Loss of Nesprin 1 and 2 does not cause abnormal
SUN 2 staining. (A) Representative immunofluorescence nuclear
images from isolated adult cardiomyocytes (B) Quantification of
percent cells with abnormal SUN 2 staining. Blue =DAPI,
Red=SUN 2 ANOVA with a post hoc Bonferroni test #p,
0.01. White Bar = 7 mm.
(TIF)
Figure S7 Loss of both Nesprin 1 and 2 had a significant impact
on the localization patterns of Lamin A/C. (A) Representative
immunofluorescence nuclear images from isolated adult cardio-
myocytes (B) Quantification of percent cells with abnormal Lamin
A/C staining. Blue =DAPI, Red=Lamin A/C ANOVA with a
post hoc Bonferroni test #p,0.01. White Bar = 7 mm Yellow
arrows =Abnormal Lamin A/C Stain.
(TIF)
Figure S8 Loss of both Nesprin 1 and 2 had a significant impact
on the localization patterns of Emerin. (A) Representative
immunofluorescence nuclear images from isolated adult cardio-
myocytes (B) Quantification of percent cells with abnormal Emerin
staining. Blue =DAPI, Red=Emerin ANOVA with a post hoc
Bonferroni test #p,0.01. White Bar = 7 mm, Yellow arrows =Ab-
normal Emerin Stain.
(TIF)
Figure S9 Representative image of isolated cardiomyocytes on
aligned, micropatterned substrates. Representative image of day
1–2 neonatal cardiomyocytes on aligned substrates. Cardiomyo-
cytes appear rod-like and form cell-cell connections. (Green= a-
actinin, Blue =DAPI, Red=Connexin-43).
(TIF)
Table S1 Real Time PCR Primers for study.
(DOCX)
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